Tag Archives: midstage

Enanta’s lung infection therapy succeeds in mid-stage trial

(Reuters) – Enanta Pharmaceuticals Inc said on Friday its treatment for a highly contagious respiratory infection met the main goal of reducing virus levels in the body in a mid-stage study. The therapy, EDP-938, developed for treating respiratory syncytial virus (RSV) infection which currently has no available treatment, also helped improve symptoms in patients compared… Read More »